171 related articles for article (PubMed ID: 16925462)
1. Proteinase-activated receptor-2 expression in breast cancer and the role of trypsin on growth and metabolism of breast cancer cell line MDA MB-231.
Matej R; Mandáková P; Netíková I; Poucková P; Olejár T
Physiol Res; 2007; 56(4):475-484. PubMed ID: 16925462
[TBL] [Abstract][Full Text] [Related]
2. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2.
Ge L; Shenoy SK; Lefkowitz RJ; DeFea K
J Biol Chem; 2004 Dec; 279(53):55419-24. PubMed ID: 15489220
[TBL] [Abstract][Full Text] [Related]
3. Signal of proteinase-activated receptor-2 contributes to highly malignant potential of human pancreatic cancer by up-regulation of interleukin-8 release.
Ikeda O; Egami H; Ishiko T; Ishikawa S; Kamohara H; Hidaka H; Takahashi M; Ogawa M
Int J Oncol; 2006 Apr; 28(4):939-46. PubMed ID: 16525644
[TBL] [Abstract][Full Text] [Related]
4. Tumor-derived trypsin enhances proliferation of intrahepatic cholangiocarcinoma cells by activating protease-activated receptor-2.
Nakanuma S; Tajima H; Okamoto K; Hayashi H; Nakagawara H; Onishi I; Takamura H; Kitagawa H; Fushida S; Tani T; Fujimura T; Kayahara M; Ohta T; Wakayama T; Iseki S; Harada S
Int J Oncol; 2010 Apr; 36(4):793-800. PubMed ID: 20198321
[TBL] [Abstract][Full Text] [Related]
5. Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation.
Sánchez-Hernández PE; Ramirez-Dueñas MG; Albarran-Somoza B; García-Iglesias T; del Toro-Arreola A; Franco-Topete R; Daneri-Navarro A
Gynecol Oncol; 2008 Jan; 108(1):19-26. PubMed ID: 17936340
[TBL] [Abstract][Full Text] [Related]
6. Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.
Yang H; Zhou H; Feng P; Zhou X; Wen H; Xie X; Shen H; Zhu X
J Exp Clin Cancer Res; 2010 Jul; 29(1):92. PubMed ID: 20618976
[TBL] [Abstract][Full Text] [Related]
7. Large isoform of MRJ (DNAJB6) reduces malignant activity of breast cancer.
Mitra A; Fillmore RA; Metge BJ; Rajesh M; Xi Y; King J; Ju J; Pannell L; Shevde LA; Samant RS
Breast Cancer Res; 2008; 10(2):R22. PubMed ID: 18328103
[TBL] [Abstract][Full Text] [Related]
8. A role for protease-activated receptor-2 in pancreatic cancer cell proliferation.
Shimamoto R; Sawada T; Uchima Y; Inoue M; Kimura K; Yamashita Y; Yamada N; Nishihara T; Ohira M; Hirakawa K
Int J Oncol; 2004 Jun; 24(6):1401-6. PubMed ID: 15138580
[TBL] [Abstract][Full Text] [Related]
9. [Effect of ERK/AP-1 signaling pathway on proliferation of hepatoma cells induced by PAR-2 agonists].
Zheng YM; Xie LQ; Li X; Zhao JY; Chen XY; Chen L; Zhou J; Li F
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3116-21. PubMed ID: 20193273
[TBL] [Abstract][Full Text] [Related]
10. Initiation of human colon cancer cell proliferation by trypsin acting at protease-activated receptor-2.
Darmoul D; Marie JC; Devaud H; Gratio V; Laburthe M
Br J Cancer; 2001 Sep; 85(5):772-9. PubMed ID: 11531266
[TBL] [Abstract][Full Text] [Related]
11. Protease-activated receptor-2 expression in IgA nephropathy: a potential role in the pathogenesis of interstitial fibrosis.
Grandaliano G; Pontrelli P; Cerullo G; Monno R; Ranieri E; Ursi M; Loverre A; Gesualdo L; Schena FP
J Am Soc Nephrol; 2003 Aug; 14(8):2072-83. PubMed ID: 12874461
[TBL] [Abstract][Full Text] [Related]
12. Evidence that protease-activated receptor-2 mediates trypsin-induced reversal of stellation in cultured rat astrocytes.
Park GH; Ryu JR; Shin CY; Choi MS; Han BH; Kim WK; Kim HC; Ko KH
Neurosci Res; 2006 Jan; 54(1):15-23. PubMed ID: 16256233
[TBL] [Abstract][Full Text] [Related]
13. Molecular characterization of the tumor-suppressive function of nischarin in breast cancer.
Baranwal S; Wang Y; Rathinam R; Lee J; Jin L; McGoey R; Pylayeva Y; Giancotti F; Blobe GC; Alahari SK
J Natl Cancer Inst; 2011 Oct; 103(20):1513-28. PubMed ID: 21917605
[TBL] [Abstract][Full Text] [Related]
14. Protease-activated receptor-2 is essential for factor VIIa and Xa-induced signaling, migration, and invasion of breast cancer cells.
Morris DR; Ding Y; Ricks TK; Gullapalli A; Wolfe BL; Trejo J
Cancer Res; 2006 Jan; 66(1):307-14. PubMed ID: 16397244
[TBL] [Abstract][Full Text] [Related]
15. Impact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinoma.
Pula B; Olbromski M; Wojnar A; Gomulkiewicz A; Witkiewicz W; Ugorski M; Dziegiel P; Podhorska-Okolow M
Cell Oncol (Dordr); 2013 Dec; 36(6):469-83. PubMed ID: 24065215
[TBL] [Abstract][Full Text] [Related]
16. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
17. Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation.
Vesey DA; Kruger WA; Poronnik P; Gobé GC; Johnson DW
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1441-9. PubMed ID: 17699557
[TBL] [Abstract][Full Text] [Related]
18. BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.
Yang S; Du J; Wang Z; Yuan W; Qiao Y; Zhang M; Zhang J; Gao S; Yin J; Sun B; Zhu T
BMC Cancer; 2007 Nov; 7():211. PubMed ID: 17997862
[TBL] [Abstract][Full Text] [Related]
19. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma.
Johnson JJ; Miller DL; Jiang R; Liu Y; Shi Z; Tarwater L; Williams R; Balsara R; Sauter ER; Stack MS
J Biol Chem; 2016 Mar; 291(13):6936-45. PubMed ID: 26839311
[TBL] [Abstract][Full Text] [Related]
20. Coagulation factor VIIa-mediated protease-activated receptor 2 activation leads to β-catenin accumulation via the AKT/GSK3β pathway and contributes to breast cancer progression.
Roy A; Ansari SA; Das K; Prasad R; Bhattacharya A; Mallik S; Mukherjee A; Sen P
J Biol Chem; 2017 Aug; 292(33):13688-13701. PubMed ID: 28522609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
